USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZO LE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE

Details for Australian Patent Application No. 2003210292 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): 102 08 986.8 28.02.02 DE

16 October 2003 Application Open to Public Inspection

Published as AU-A-2003210292

23 October 2003 Application Open to Public Inspection

Published as AU-A-2003210292

22 December 2005 Assignment before Grant

Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

3 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.